Title: This act summary is provided for the convenience of the public and members of the General Assembly. It
Official Title: This act summary is provided for the convenience of the public and members of the General Assembly. It
Number of Sections: 1
Source: versions - Act Summary
Media Type: application/pdf
Strikethrough Detection: 1 sections found

================================================================================

Section 1:
Act No. 53 Page 1 of 1
2025
is intended to provide a general summary of the act and may not be exhaustive. It has been prepared by the
staff of the Office of Legislative Counsel without input from members of the General Assembly. It is not
intended to aid in the interpretation of legislation or to serve as a source of legislative intent.
Act No. 53 (H.209). An act relating to intranasal epinephrine in schools
Subjects: Education; health; schools; intranasal epinephrine; prescribing and
dispensing authority
This act expands the definition of epinephrine from epinephrine auto-injectors to any
U.S. Food and Drug Administration-approved single-dose epinephrine delivery system,
including intranasal epinephrine. As a result, this act allows a health care professional to
prescribe and issue standing orders for the use of any U.S. Food and Drug
Administration-approved single-dose epinephrine delivery system in schools. It allows a
school to maintain a stock supply of epinephrine, including intranasal epinephrine. It
further allows a school administrator to authorize school nurses or other designated
personnel to administer or have a student self-administer epinephrine in accordance with
a student’s plan of action for managing the student’s life-threatening allergy, which may
include intranasal epinephrine.
Effective Date: July 1, 2025
VT LEG #384155 v.2
[DELETED:  P]


================================================================================

Raw Text:
Act No. 53 Page 1 of 1
2025
This act summary is provided for the convenience of the public and members of the General Assembly. It
is intended to provide a general summary of the act and may not be exhaustive. It has been prepared by the
staff of the Office of Legislative Counsel without input from members of the General Assembly. It is not
intended to aid in the interpretation of legislation or to serve as a source of legislative intent.
Act No. 53 (H.209). An act relating to intranasal epinephrine in schools
Subjects: Education; health; schools; intranasal epinephrine; prescribing and
dispensing authority
This act expands the definition of epinephrine from epinephrine auto-injectors to any
U.S. Food and Drug Administration-approved single-dose epinephrine delivery system,
including intranasal epinephrine. As a result, this act allows a health care professional to
prescribe and issue standing orders for the use of any U.S. Food and Drug
Administration-approved single-dose epinephrine delivery system in schools. It allows a
school to maintain a stock supply of epinephrine, including intranasal epinephrine. It
further allows a school administrator to authorize school nurses or other designated
personnel to administer or have a student self-administer epinephrine in accordance with
a student’s plan of action for managing the student’s life-threatening allergy, which may
include intranasal epinephrine.
Effective Date: July 1, 2025
VT LEG #384155 v.2

[DELETED:  P]